Top compounds associated with response to OR2L13


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib GDSC1000 pan-cancer AAC 0.014 0.7
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA AGK-2 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA Irinotecan gCSI pan-cancer AAC -0.022 0.7
mRNA CCT018159 GDSC1000 pan-cancer AAC -0.013 0.7
mRNA BRD-K09344309 CTRPv2 pan-cancer AAC -0.03 0.7
mRNA VAF-347 CTRPv2 pan-cancer AAC -0.018 0.7
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA GSK525762A CTRPv2 pan-cancer AAC 0.012 0.7
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC -0.02 0.7
Download CSV